SEATTLE GENETICS, INC.

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 94161
 
  
 
C07K PEPTIDES 6275
 
  
 
C07D HETEROCYCLIC COMPOUNDS 10152
 
  
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 990
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 8198
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 7160
 
  
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 693
 
  
 
A61N ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY 2105
 
  
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 2123
 
  
 
A01N PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF 194

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2018/0028,681 COMBINATION THERAPY USING A CD19-ADC AND VINCRISTINEFeb 12, 16Feb 01, 18[A61K, C07K]
2017/0333,556 DOSAGE AND ADMINISTRATION OF NON-FUCOSYLATED ANTI-CD40 ANTIBODIESOct 29, 15Nov 23, 17[A61K, C07K]
2017/0298,118 METHODS FOR SCREENING ANTIBODIESJun 28, 17Oct 19, 17[G01N, C07K]
2017/0247,412 TARGETED DELIVERY OF TERTIARY AMINE-CONTAINING DRUG SUBSTANCESSep 10, 15Aug 31, 17[C07H, C07K]
2017/0233,484 BCMA ANTIBODIES AND USE OF SAME TO TREAT CANCER AND IMMUNOLOGICAL DISORDERSFeb 16, 17Aug 17, 17[A61K, C07K]
2017/0216,391 HYDROPHILIC ANTIBODY-DRUG CONJUGATESFeb 17, 15Aug 03, 17[A61K]
2017/0189,542 BETA-GLUCURONIDE-LINKER DRUG CONJUGATESMar 20, 17Jul 06, 17[A61K, C07K]
2017/0182,178 OPTIMAL DOSING OF A CD19-ANTIBODY DRUG CONJUGATEApr 07, 15Jun 29, 17[A61K, C07K]
2017/0028,062 STABLE FORMULATIONS FOR ANTI-CD19 ANTIBODIES AND ANTIBODY-DRUG CONJUGATESApr 07, 15Feb 02, 17[A61J, A61K, C07K]
2016/0193,359 NEW BINDER-DRUG CONJUGATES (ADCS) AND USE THEREOFFeb 24, 16Jul 07, 16[A61K, C07K]

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9919061 CD19 binding agents and uses thereofJun 18, 15Mar 20, 18[A61K, C07K]
9816069 Methods and compositions for making antibodies and antibody derivatives with reduced core fucosylationFeb 26, 15Nov 14, 17[C07H, C12N, C07K]
9783608 Humanized antibodies to LIV-1 and use of same to treat cancerNov 20, 15Oct 10, 17[A61K, C07K]
9731030 β-glucuronide-linker drug conjugatesSep 25, 13Aug 15, 17[A61K]
9732084 Pyrrolobenzodiazepines used to treat proliferative diseasesNov 06, 13Aug 15, 17[A61K, C07D]
9725500 Methods for screening antibodiesFeb 28, 11Aug 08, 17[A61K, C07K]
9713647 Pyrrolobenzodiazepines and targeted conjugatesJun 14, 16Jul 25, 17[A61K, C07D]
9713648 Weekly dosing regimens for anti-CD30 VC-PAB-MMAE antibody drug-conjugatesNov 11, 15Jul 25, 17[A61K, C07K]
9707301 Pyrrolobenzodiazepines and targeted conjugatesJun 15, 16Jul 18, 17[A61K, C07D, C07K]
9708404 Anti-NTB-A antibodies and related compositions and methodsDec 20, 13Jul 18, 17[A61K, C07K]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2017/0143,846 TARGETED PYRROLOBENZODIAZAPINE CONJUGATESAbandonedFeb 01, 17May 25, 17[A61K, C07K]
9387258 Pyrrolobenzodiazepines and targeted conjugatesWithdrawnOct 12, 12Jul 12, 16[A61K, C07D]
2016/0003,847 Detection and Treatment of Pancreatic, Ovarian and Other CD70 Positive CancersAbandonedJul 13, 15Jan 07, 16[G01N, C07K]
2015/0246,136 NOVEL BINDER-DRUG CONJUGATES (ADCs) AND USE OF SAMEAbandonedMay 11, 15Sep 03, 15[A61K, C07K]
2015/0238,633 ANTIBODY DRUG CONJUGATES (ADC) THAT BIND TO 158P1D7 PROTEINSAbandonedFeb 27, 15Aug 27, 15[A61K]
2015/0148,298 N-CARBOXYALKYL-AURISTATIN AND USE THEREOFAbandonedFeb 05, 15May 28, 15[C07K]
2015/0079,114 DR5 LIGAND DRUG CONJUGATESAbandonedApr 23, 13Mar 19, 15[A61K, C07K]
2015/0030,618 NOVEL BINDER-DRUG CONJUGATES (ADCS) AND USE THEREOFAbandonedMay 05, 14Jan 29, 15[A61K, C07K]
2015/0023,989 NEW ANTIBODY DRUG CONJUGATES (ADCS) AND THE USE THEREOFAbandonedDec 12, 12Jan 22, 15[A61K]
2014/0220,047 MONOMETHYLVALINE COMPOUNDS CAPABLE OF CONJUGATION TO LIGANDSAbandonedFeb 28, 14Aug 07, 14[A61K]
2014/0193,405 HUMANIZED ANTI-CD40 ANTIBODIESAbandonedMar 10, 14Jul 10, 14[C07K]
2014/0127,240 Novel Binder-Drug Conjugates (ADCs) and Use of SameAbandonedApr 20, 12May 08, 14[A61K, C07K]
2014/0086,942 Variant Target Binding Agents and Uses ThereofAbandonedMar 14, 13Mar 27, 14[A61K]
2013/0315,900 HUMANIZED ANTI-CD40 ANTIBODIES CONJUGATED TO THERAPEUTIC AGENTSAbandonedJun 25, 13Nov 28, 13[C07K]
2013/0309,223 CD33 Antibodies And Use Of Same To Treat CancerAbandonedMar 14, 13Nov 21, 13[C07K]
2013/0280,282 DR5 LIGAND DRUG CONJUGATESAbandonedMar 14, 13Oct 24, 13[A61K]
2013/0136,756 ANTIBODY DRUG CONJUGATES (ADC) THAT BIND TO 24P4C12 PROTEINSAbandonedNov 08, 12May 30, 13[A61K, C07K]
2013/0122,024 NEW BINDER-DRUG CONJUGATES (ADCS) AND USE THEREOFAbandonedApr 20, 12May 16, 13[A61K, C07K]
2012/0294,863 Anti-CD70 Antibody and Its Use for the Treatment and Prevention of Cancer and Immune DisordersAbandonedAug 03, 12Nov 22, 12[A61K, A61P]
2012/0148,608 MONOMETHYLVALINE COMPOUNDS CAPABLE OF CONJUGATION TO LIGANDSAbandonedFeb 15, 12Jun 14, 12[A61K, C07K]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.